Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Anti-EGFR therapy and antiangiogenic therapies are used alone or in combination with chemotherapies to improve survival in metastatic colorectal cancer. However, it is unknown whether pretreatment with antiangiogenic therapy could impact on the efficacy of anti-EGFR therapy. We selected one hundred...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Derangère, Valentin, Fumet, Jean David, Boidot, Romain, Bengrine, Leila, Limagne, Emeric, Chevriaux, Angélique, Vincent, Julie, Ladoire, Sylvain, Apetoh, Lionel, Rébé, Cédric, Ghiringhelli, François
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891042/
https://ncbi.nlm.nih.gov/pubmed/26824184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia